Back to News
Feb 24, 2026 8:40 AM

Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences

Hims & Hers Health Inc. (NYSE:HIMS) shares are down during Tuesday’s premarket session as the company reported mixed fourth-quarter earnings results.

The stock’s decline follows a report that revealed revenue missed analyst expectations, adding pressure as broader markets experienced slight gains on the previous trading day.

HIMS Q4 Earnings Miss Revenue Forecasts

Hims & Hers Health reported fourth-quarter revenue of $617.82 million, falling short of analyst estimates of $619.22 million. However, the company did beat earnings expectations with a reported 8 cents per share, surpassing estimates of 3 cents per share.

The company noted that total revenue was up 28% year-over-year, with subscriber numbers growing to over 2.5 million, a 13% increase from 2025.

Outlook Excludes Eucalyptus Transaction

Hims & Hers also provided guidance for first-quarter revenue between $600 million and $625 million, which is below the analyst estimate of $653.12 million.

The company expects fiscal 2026 sales of ...